share_log

BRIEF-Biocryst Pharmaceuticals - On March 18, Co Withdrew Its Application For Orphan Medicinal Product Designation For Orladeyo

BRIEF-Biocryst Pharmaceuticals - On March 18, Co Withdrew Its Application For Orphan Medicinal Product Designation For Orladeyo

簡介-Bicryst PharmPharmticals-3月18日，Co撤回了Orladeyo的孤兒藥物產品指定申請
路透社 ·  2021/03/19 06:13

March 18 (Reuters) - BioCryst Pharmaceuticals Inc :
   * BIOCRYST PHARMACEUTICALS - ON MARCH 18, CO WITHDREW ITS APPLICATION FOR ORPHAN MEDICINAL PRODUCT DESIGNATION FOR ORLADEYO™ (BEROTRALSTAT) IN THE EU

Source text for Eikon: [ID: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;)

路透3月18日電-BioCryst PharmPharmticals Inc：*BioCryst PharmPharmticals-3月18日，CO撤回了其在歐盟為ORLADEYO™(BEROTRALSTAT)指定孤兒藥品的申請Eikon的源文本：[ID：進一步的公司覆蓋範圍：(Reurs.Briefs@thomsonreurs.com；)

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論